About UsA clinical-stage biotechnology company focused on dermatology, wound care, and infectious disease.Read More News Releases Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates March 31, 2026 Read More Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group March 24, 2026 Read More Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs February 17, 2026 Read More All News Releases
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates March 31, 2026 Read More
Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group March 24, 2026 Read More
Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs February 17, 2026 Read More
